This clinical study investigates the effects and safety of a topical cosmetic product containing postbiotics (Bifida ferment extract and Pediococcus ferment extract) in women aged 35-60 with visible signs of skin aging.
The study is a 3-month, single-center, intra-subject controlled trial involving 45 Caucasian women with sensitive or normal skin. Participants will apply 1 ml of the product twice daily. Clinical evaluations will be conducted at baseline and at 1 month, 2 months, and 3 months, using validated dermatological scales and non-invasive instruments (AEVA3D, Mexameter®, MoistureMap®, Cutometer®, Tewameter®, Clarius®, Glossymeter®).
Safety will be assessed through systematic monitoring of adverse events, with serious adverse events expected to remain below 1%. Subjective perception will be evaluated via structured questionnaires.
Female participants.
Age between 35 and 60 years.
All skin types (combination, oily, dry, and/or normal).
Skin condition: 50% sensitive skin and 50% normal skin.
Pregnant or breastfeeding women.
History of allergy to cosmetic products and/or dietary supplements.
Known allergy or hypersensitivity to any component of the product.
History or current diagnosis of cancer.
AB Biotics, SA
Lead sponsor
Dr. Goya Análisis, SL.
Collaborator